Clinical study on the improvement of mid-term prognosis of acute coronary syndrome based on the utilization of multi-biomarkers usage and risk stratification.
http://www.chictr.org.cn/showprojen.aspx?proj=23764
Recruiting status： Recruiting
Reference Standard:
cTnI, ECG and coronary angiography
Index test:
KIM1; Midkine; ApoA-I glycation
Definition :
(Source: NCBI)
From
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases (2014)
http://onlinelibrary.wiley.com/doi/10.1111/bph.12601/full
Clinical Study: Midkine In Multi-Biomarker Prognosis of ACS
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $3.691M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $8.671K | 1.051M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1735002 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |